Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
KanekaKANKF 79 Equity-to-Asset is 0.52 as of Mar. 2026, which is at its 10-year median of 0.52. GuruFocus rates KANKF with a GF Score™ of 79/100 and a GF Value™ of $22.03. The stock has 8 warning signs investors should review. Among 1,619 Chemicals companies, Kaneka ranks worse than 61.33% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Kaneka's Total Stockholders Equity for the quarter that ended in Mar. 2026 was $3,147 Mil. Kaneka's Total Assets for the quarter that ended in Mar. 2026 was $6,044 Mil.
Therefore, Kaneka's Equity to Asset Ratio for the quarter that ended in Mar. 2026 was 0.52.
The historical rank and industry rank for Kaneka's Equity-to-Asset or its related term are showing as below:
KANKF'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.51 Med: 0.52 Max: 0.54
Current: 0.51
During the past 13 years, the highest Equity to Asset Ratio of Kaneka was 0.54. The lowest was 0.51. And the median was 0.52.
KANKF's Equity-to-Asset is ranked worse than 61.33% of 1619
companies
in the Chemicals industry
Industry Median: 0.6
vs KANKF: 0.51
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Kaneka Equity-to-Asset Related Terms
Kaneka Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Kaneka's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KANKF vs LIN, SHW, ECL: Equity-to-Asset Comparison
For the Specialty Chemicals subindustry, Kaneka's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kaneka Equity-to-Asset vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Kaneka's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Kaneka's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Kaneka's Equity to Asset Ratio for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kaneka (KANKF) has a Equity-to-Asset of 0.52 as of Mar. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Kaneka and its competitors. This is near median its historical median of 0.52. Over the past decade, Kaneka's Equity-to-Asset has ranged from 0.51 to 0.54. According to the industry distribution chart, Kaneka ranks #993 out of 1619 companies in the Chemicals industry, placing it in the top 61.3%.
Is Kaneka's Equity-to-Asset too high?
Kaneka's current Equity-to-Asset of 0.52 is near median its 10-year median of 0.52. Over the past 10 years, this metric has ranged from a low of 0.51 to a high of 0.54. The Chemicals industry median Equity-to-Asset is 0.60. Kaneka's value of 0.52 is 13.3% below this industry median. Based on the distribution chart, Kaneka ranks #993 out of 1619 companies in the Chemicals industry, which is below the industry midpoint. Overall, Kaneka has a GF Score™ of 79/100, reflecting its overall financial health beyond just this single metric.
How does Kaneka's Equity-to-Asset compare to LIN and SHW?
According to the Chemicals industry distribution chart, Kaneka ranks #993 out of 1619 companies for Equity-to-Asset. This places Kaneka in the lower half of its industry. The industry median Equity-to-Asset is 0.60. Kaneka's value of 0.52 is 13.3% below this benchmark. Historically, Kaneka's own Equity-to-Asset has ranged from 0.51 to 0.54 over the past decade. While the company's 10-year median is 0.52 vs. the industry median of 0.60, Kaneka has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Chemicals company?
The median Equity-to-Asset among Chemicals companies is 0.60, based on 1,619 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kaneka's current Equity-to-Asset of 0.52 is 13.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Kaneka and its competitors. For the Chemicals industry, the median Equity-to-Asset is 0.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kaneka's current Equity-to-Asset is 0.52, which is near median its own 10-year median of 0.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kaneka stock overvalued right now?
Kaneka (KANKF) has a current Equity-to-Asset of 0.52. The stock's GF Value™ is $22.03, compared to a current price of $30.28 — trading 37.4% above its estimated fair value. The current Equity-to-Asset is 0.52, which is near median its 10-year median of 0.52 and 13.3% below the Chemicals industry median of 0.60. Kaneka's overall GF Score™ is 79/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Kaneka (KANKF), the current Equity-to-Asset is 0.52 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kaneka (KANKF) Overvalued in 2026?
Based on GuruFocus' analysis, Kaneka stock appears to be overvalued.
The current stock price of $30.28 is trading 37.4% above its estimated GF Value™ of $22.03.
Key valuation signals for KANKF:
Equity-to-Asset: 0.52 (near median its 10-year median of 0.52)
GF Value™: $22.03 vs. price of $30.28 (37.4% above fair value)
Industry Position: 13.3% below the Chemicals median (#993 of 1619)
No single metric tells the full story. See the KANKF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kaneka Corp manufactures and sells a variety of chemicals, plastics, and chemical-based products. The company organizes itself into seven segments based on product type. The foodstuffs segment, which generates more revenue than any other segment, sells margarine, shortening, bakery yeast and spices. The chemicals segment sells polyvinyl chloride used in pipes and flooring. The functional and expandable products segments sell polystyrene- and silicone-based products. The life science products segment sells medical devices, which include balloon catheters for vessel stenosis, and pharmaceutical ingredients. The electronic products segment sells heat resistant films and optical materials. The synthetic fibers segment sells fibers used to make apparel. The majority of revenue comes from Japan.
79GF Score
Get the complete analysis for KANKF
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KANKF has been successfully added to your 
